Home » Pharmaceutical industry

Tag

Pharmaceutical industry

Legislation and Regulation

China emerges as world’s fastest-growing pharmaceutical industry

Here, we look at how China is emerging as the fastest-growing pharmaceutical sector in the world.

Growth Planning

How viable is the UK pharmaceuticals market for Amazon?

Amazon is eyeing up a lucrative new sector, the multi-billion pound pharmacy industry. But the UK medicines market might leave Amazon with a nasty taste in its mouth, warns ParcelHero's David Jinks.

Mergers & Acquisitions

Shire’s acquisition of NPS Pharmaceuticals ‘makes good sense’

Warwick Business School academic welcomes deal.

News

Abbey Pharma inks Business Growth Fund deal and closes acquisition

Kent-based Abbey Pharma has taken on external debt and equity finance so that it can support a planned buy-and-build strategy.

News

Angel CoFund makes investment in pharmaceutical space

Destiny Pharma has secured the investment capital it needs to finance a clinical trial for its drug aimed at dealing with antibiotic-resistant bacteria.

Mergers & Acquisitions

Penn Pharmaceuticals sale set to net LDC three times return on investment

LDC has exited a seven-year investment in Penn Pharmaceuticals by selling the healthcare-orientated business to Packaging Coordinators.

News

British medical company Acacia Pharma secures £15 million funding

A Series B venture capital financing round worth £15 million has been led by Fidelity Biosciences and Novo A/S.

News

YFM Equity Partners exits Fishawack in deal with Growth Capital Partners

Medical communications agency Fishawack has a new private equity backer through a secondary buy-out deal.

News

Invesco Asset Management makes healthcare play with medicine investment

A £25 million fundraising for infirst HEALTHCARE will be used to launch the company's medicines into the US market.

News

Lamellar Biomedical gets £3.3 million capital injection to develop treatments

A Scottish biomedical company has received the support of a number of equity backers as it looks to continue with the commercialisation of its products.

News

SPARK Impact fund invests in drug discovery company

The North West Fund for Biomedical, the £25 million fund managed by SPARK Impact, has invested £350,000 into drug discovery company Molplex Ltd.

News

Herpes drug business joins AIM

Pharmaceuticals products and services business Clinigen Group has begun life on the Alternative Investment Market.

Recommended Content